1. FDA approves Sarepta’s DMD drug that it had previously rejected — Biogen chalks up another failure — The House passes the Lower Drug Costs Now Act, but it’s unlikely to become law — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Wolters Kluwer Health

Anonymous board for Wolters Kluwer Health


Sort By:
Title
Replies Views
Last Message
  1. anonymous
    Replies:
    0
    Views:
    1,892
  2. Anonymous
    Replies:
    0
    Views:
    2,418
  3. Anonymous
    Replies:
    2
    Views:
    3,888
  4. Anonymous
    Replies:
    1
    Views:
    3,004
  5. Anonymous
    Replies:
    8
    Views:
    4,617
  6. Anonymous
    Replies:
    6
    Views:
    5,407
  7. Anonymous
    Replies:
    11
    Views:
    10,934
  8. Anonymous
    Replies:
    34
    Views:
    16,971

Thread Display Options

Loading...